Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Psychiatry|September 26, 2022
Longitudinal trends in the prevalence and treatment of depression among adults with cardiovascular disease: An analysis of national health and nutrition examination survey 2009-2020Zhen Feng, Wai Kei Tong, Zhijia Tang
Pharmacological Research|September 7, 2019
Pediatric drug development in China: Reforms and challengesWeijia Wu, Zhijia Tang, Jiyuan Chen, et al.
Archives of Gerontology and Geriatrics|March 7, 2025
Sodium-glucose cotransporter 2 inhibitors in the treatment of heart failure patients: A systematic review and meta-analysis of cost-utility studiesXinyue Zhang, Yanxia Zhang, Jiayu Wang, et al.
BMJ Open|November 21, 2022
Changes in pharmaceutical retail market and regional inequality of community pharmacists accessibility in mainland China: a retrospective cross-sectional studyZhen Feng, Yun Ye, Hua Ye, et al.
Frontiers in Pharmacology|August 25, 2023
Cost-effectiveness analysis of once-daily oral semaglutide versus placebo and subcutaneous glucagon-like peptide-1 receptor agonists added to insulin in patients with type 2 diabetes in ChinaZhen Feng, Wai Kei Tong, Xinyue Zhang, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 3, 2024
The impact of dipeptidyl peptidase 4 inhibitors on health-related quality of life in patients with type 2 diabetes mellitus: a systematic review and meta-analysisXinyue Zhang, Wai Kei Tong, Qian Xia, et al.
BMC Psychiatry|July 10, 2023
Prevalence of depression and association with all-cause and cardiovascular mortality among individuals with type 2 diabetes: a cohort study based on NHANES 2005-2018 dataZhen Feng, Wai Kei Tong, Xinyue Zhang, et al.
International Journal of Environmental Research and Public Health|October 17, 2020
Current Perceptions and Improvement Approaches of Pharmaceutical Care Capacity of Community Pharmacists: A Quantitative Analysis Based on Survey Data at Chinese Chain PharmaciesZhijia Tang, Pema Lhamu, Hua Ye, et al.
Pharmacological Research|May 20, 2020
Regulatory oversight of cell therapy in China: Government's efforts in patient access and therapeutic innovationWeijia Wu, Yuanyuan Wang, Zhijia Tang, et al.
Frontiers in Pharmacology|August 29, 2022
Case Report: Rhabdomyolysis secondary to vildagliptin overdose in a suicidal attempt: A case report and brief literature reviewZhijia Tang, Xiaofang Fan, Zhen Feng, et al.
Pageof 4